Log In
BCIQ
Print this Print this
 

Iotrex

  Manage Alerts
Collapse Summary General Information
Company Dr. Reddy's Laboratories Ltd.
DescriptionAqueous radiotherapy solution containing sodium 3-(125I)iodo-4-hydroxybenzenesulfonate (125I-HBS)
Molecular Target
Mechanism of Action 
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentMarketed
Standard IndicationBrain cancer
Indication DetailsTreat brain cancer
Regulatory Designation
PartnerIsoRay Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

06/08/2011

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today